Spain · Delayed Price · Currency is EUR BME:DIA Statistics
Total Valuation
BME:DIA has a market cap or net worth of EUR 2.22 billion. The enterprise value is 2.84 billion.
| Market Cap | 2.22B |
| Enterprise Value | 2.84B |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:DIA has 57.99 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 57.99M |
| Shares Outstanding | 57.99M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 4.43% |
| Float | 12.85M |
Valuation Ratios
The trailing PE ratio is 20.00 and the forward PE ratio is 21.22. BME:DIA's PEG ratio is 1.33.
| PE Ratio | 20.00 |
| Forward PE | 21.22 |
| PS Ratio | 0.37 |
| PB Ratio | 12.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.44 |
| P/OCF Ratio | 4.10 |
| PEG Ratio | 1.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.68, with an EV/FCF ratio of 8.24.
| EV / Earnings | 24.67 |
| EV / Sales | 0.47 |
| EV / EBITDA | 5.68 |
| EV / EBIT | 13.89 |
| EV / FCF | 8.24 |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 5.71.
| Current Ratio | 0.57 |
| Quick Ratio | 0.36 |
| Debt / Equity | 5.71 |
| Debt / EBITDA | 2.02 |
| Debt / FCF | 2.93 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 141.30% and return on invested capital (ROIC) is 25.66%.
| Return on Equity (ROE) | 141.30% |
| Return on Assets (ROA) | 5.41% |
| Return on Invested Capital (ROIC) | 25.66% |
| Return on Capital Employed (ROCE) | 20.47% |
| Weighted Average Cost of Capital (WACC) | 8.20% |
| Revenue Per Employee | 368,503 |
| Profits Per Employee | 7,085 |
| Employee Count | 16,253 |
| Asset Turnover | 2.53 |
| Inventory Turnover | 16.89 |
Taxes
| Income Tax | -34.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.90% in the last 52 weeks. The beta is 0.66, so BME:DIA's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +49.90% |
| 50-Day Moving Average | 40.26 |
| 200-Day Moving Average | 38.64 |
| Relative Strength Index (RSI) | 39.03 |
| Average Volume (20 Days) | 36,584 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:DIA had revenue of EUR 5.99 billion and earned 115.15 million in profits. Earnings per share was 1.98.
| Revenue | 5.99B |
| Gross Profit | 1.48B |
| Operating Income | 204.51M |
| Pretax Income | 77.06M |
| Net Income | 115.15M |
| EBITDA | 335.65M |
| EBIT | 204.51M |
| Earnings Per Share (EPS) | 1.98 |
Balance Sheet
The company has 390.16 million in cash and 1.01 billion in debt, with a net cash position of -620.05 million or -10.69 per share.
| Cash & Cash Equivalents | 390.16M |
| Total Debt | 1.01B |
| Net Cash | -620.05M |
| Net Cash Per Share | -10.69 |
| Equity (Book Value) | 176.85M |
| Book Value Per Share | 3.05 |
| Working Capital | -640.46M |
Cash Flow
In the last 12 months, operating cash flow was 541.85 million and capital expenditures -197.07 million, giving a free cash flow of 344.78 million.
| Operating Cash Flow | 541.85M |
| Capital Expenditures | -197.07M |
| Depreciation & Amortization | 131.14M |
| Net Borrowing | -221.58M |
| Free Cash Flow | 344.78M |
| FCF Per Share | 5.95 |
Margins
Gross margin is 24.67%, with operating and profit margins of 3.41% and 1.92%.
| Gross Margin | 24.67% |
| Operating Margin | 3.41% |
| Pretax Margin | 1.29% |
| Profit Margin | 1.92% |
| EBITDA Margin | 5.60% |
| EBIT Margin | 3.41% |
| FCF Margin | 5.76% |
Dividends & Yields
BME:DIA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 5.18% |
| FCF Yield | 15.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:DIA is 49.78, which is 29.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 49.78 |
| Price Target Difference | 29.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 5.68% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on February 5, 2025. It was a reverse split with a ratio of 0.001.
| Last Split Date | Feb 5, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
BME:DIA has an Altman Z-Score of 2.82 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.82 |
| Piotroski F-Score | 7 |